[
    [
        {
            "time": "",
            "original_text": "【解盘论市】创业板本周涨逾5%，一切都是最好的安排",
            "features": {
                "keywords": [
                    "创业板",
                    "涨逾5%",
                    "最好安排"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "创业板"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【解盘论市】创业板本周涨逾5%，一切都是最好的安排",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白云山2品种抗生素未通过一致性评价",
            "features": {
                "keywords": [
                    "白云山",
                    "抗生素",
                    "未通过",
                    "一致性评价"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "白云山2品种抗生素未通过一致性评价",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[买入评级]医药生物行业深度分析报告：政策回暖 渠道模式改善 品牌OTC迎来黄金时代",
            "features": {
                "keywords": [
                    "买入评级",
                    "医药生物",
                    "政策回暖",
                    "渠道模式改善",
                    "品牌OTC",
                    "黄金时代"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "品牌OTC"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]医药生物行业深度分析报告：政策回暖 渠道模式改善 品牌OTC迎来黄金时代",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]